Michael Rapp's Net Worth
Michael Rapp's net worth is estimated to be at least $3,416,930.02 as of 12/23/2024. CoreStreet's estimation of Michael Rapp's net worth is based on their sale of stock and current holding of stock.
Michael Rapp is Director at Immunome Inc. They have executed at least 10 trades of stock as per SEC Form 4 filings. Their most recent trade was for 25,962 units of IMNM stock on 09/13/2021. Their biggest sale was on when they sold units of stock for $. They typically trade 2 times per year.
Total value of insider buys:
- $3,416,930.02
Total value of insider sells:
- $0.00
Most recent insider trade:
- Sept. 13, 2021
Michael Rapp's Insider Trading History
| Immunome Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 13, 2021 | Director | 25,962 | $19.96 | Buy | $518,201.52 |
Sept. 9, 2021 | Director | 30,450 | $18.19 | Buy | $553,885.50 |
Oct. 6, 2020 | Director | 83,332 | $12.00 | Buy | $999,984.00 |
| Zynerba Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 30, 2018 | Major Shareholder | 5,885 | $10.45 | Buy | $61,498.25 |
May 2, 2018 | Major Shareholder | 15,000 | $10.46 | Buy | $156,900.00 |
March 22, 2018 | Major Shareholder | 10,000 | $9.28 | Buy | $92,800.00 |
Jan. 2, 2018 | Major Shareholder | 15,000 | $12.99 | Buy | $194,850.00 |
Oct. 23, 2017 | Major Shareholder | 25,745 | $9.94 | Buy | $255,905.30 |
Oct. 19, 2017 | Major Shareholder | 44,255 | $9.59 | Buy | $424,405.45 |
Dec. 29, 2016 | Major Shareholder | 10,000 | $15.85 | Buy | $158,500.00 |